New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis ...Middle East

BRUSSELS, Belgium and ATLANTA, Aug. 7, 2021 /PRNewswire/ -- UCB, a global biopharmaceutical company, announced today new interim data from BE BRIGHT, an open-label extension (OLE) trial to assess the long-term safety, tolerability and efficacy of bimekizumab, an investigational IL-17A and...

Hence then, the article about new two year data showed bimekizumab maintained high levels of skin clearance in patients with moderate to severe plaque psoriasis was published today ( Saturday 07/08/2021 - 09:46 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis )

Also on site :

• Cyberattack hits Canvas system used by thousands of schools as finals loom
• Leak points to insider who allegedly helped Zelensky crony escape justice – media
• Driving less, canceling vacations, and tightening budgets: All the ways Americans are coping with soaring gas prices